Home / Business and Economy / DRI Healthcare Stock: Price Target Tweak
DRI Healthcare Stock: Price Target Tweak
29 Nov, 2025
Summary
- DRI Healthcare Trust's price target was slightly lowered to CA$20.14.
- Analysts from CIBC and RBC Capital maintain positive ratings.
- Modest target increases suggest potential near-term price reflections.
DRI Healthcare Trust has seen its fair value price target marginally adjusted to CA$20.14 from CA$20.17. This subtle change reflects stable discount rates and slightly enhanced revenue growth forecasts.
Analysts from CIBC and RBC Capital have recently offered commentary, largely favoring the company's trajectory. CIBC, for instance, raised its price target to C$19.50, while RBC Capital increased theirs to C$21, both retaining Outperform ratings. These upward revisions underscore a positive analyst consensus.
However, the scale of these increases has led to some analyst reservations, potentially indicating that current share prices already reflect good news. While no significant bearish downgrades have occurred, the measured approach to target hikes suggests analysts perceive potential near-term risks.
